EQUILLIUM, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EQUILLIUM, INC. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $35.72M.
- EQUILLIUM, INC. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $252.00K.
- EQUILLIUM, INC. stock issued during period, value, new issues for fiscal 2020 was $252.00K.
- EQUILLIUM, INC. stock issued during period, value, new issues for fiscal 2018 was $44.00.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2020-12-31 | $252.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $35.72M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $252.00K 10-Q · filed 2021-11-10 | |
| 2018-12-31 | $44.00 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |